Literature DB >> 9561776

Entamoeba dispar: cultivation with sterilized Crithidia fasciculata.

S Kobayashi1, E Imai, H Tachibana, T Fujiwara, T Takeuchi.   

Abstract

Four isolates of Entamoeba dispar identified by their hexokinase and phosphoglucomutase isoenzyme profile and by their failure to react with Entamoeba histolytica-specific monoclonal antibody (4G6) could be grown in either Diamond's BI-S-33 medium, newly developed BCSI-S (Biosate cysteine starch iron-serum) medium, or casein-free YI-S medium in the presence of Crithidia fasciculata (ReF-1:PRR) sterilized by heating 56 degrees C for 30 min and subsequent incubation with 1% hydrogen peroxide for 24 hours at 4 degrees C. After the cultures were maintained for over 50 passages, the amebae were identified as E. dispar by isoenzyme analysis, polymerase chain reaction with E. histolytica- and E. dispar-specific primers, i.e. p11 plus p12 and p13 plus p14, respectively, and by negative reactivity with monoclonal antibody 4G6. The flagellates added to the culture were judged to be metabolically inactive based on the results of nuclear magnetic resonance spectroscopy, electron microscopy, and polarographic analysis. All of these findings suggest that E. dispar can grow in vitro with metabolically inactive C. fasciculata as a culture associate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9561776     DOI: 10.1111/j.1550-7408.1998.tb04516.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  8 in total

Review 1.  Methods for cultivation of luminal parasitic protists of clinical importance.

Authors:  C Graham Clark; Louis S Diamond
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

2.  Development of monoclonal antibodies which specifically recognize Entamoeba histolytica in preserved stool samples.

Authors:  Y C Yau; I Crandall; K C Kain
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

3.  Remarkable genetic polymorphism among Entamoeba histolytica isolates from a limited geographic area.

Authors:  Ali Haghighi; Seiki Kobayashi; Tsutomu Takeuchi; Gohta Masuda; Tomoyoshi Nozaki
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Improved affinity of a human anti-Entamoeba histolytica Gal/GalNAc lectin Fab fragment by a single amino acid modification of the light chain.

Authors:  Hiroshi Tachibana; Naohisa Matsumoto; Xun-Jia Cheng; Hideo Tsukamoto; Eisaku Yoshihara
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

Review 5.  Laboratory diagnosis of amebiasis.

Authors:  Mehmet Tanyuksel; William A Petri
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

6.  VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit.

Authors:  Hiroshi Tachibana; Katsuomi Watanabe; Xun-Jia Cheng; Hideo Tsukamoto; Yoshimasa Kaneda; Tsutomu Takeuchi; Seiji Ihara; William A Petri
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 7.  Laboratory diagnostic techniques for Entamoeba species.

Authors:  R Fotedar; D Stark; N Beebe; D Marriott; J Ellis; J Harkness
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

8.  Entamoeba dispar: A Rare Case of Enteritis in a Patient Living in a Nonendemic Area.

Authors:  Rosalia Graffeo; Carola Maria Archibusacci; Silvia Soldini; Lucio Romano; Luca Masucci
Journal:  Case Rep Gastrointest Med       Date:  2014-02-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.